TherapeuticsMD, Inc. (TXMD)
1.76
-0.08
(-4.35%)
USD |
NASDAQ |
Dec 12, 16:00
1.76
0.00 (0.00%)
After-Hours: 20:00
TherapeuticsMD Market Cap: 20.37M for Dec. 12, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 171.10B |
| Eli Lilly & Co. | 920.88B |
| Pfizer Inc. | 147.03B |
| AbbVie, Inc. | 394.66B |
| NovaBay Pharmaceuticals, Inc. | 354.09M |
Market Cap Related Metrics
| PE Ratio | 67.69 |
| PS Ratio | 7.275 |
| Price to Book Value | 0.7423 |
| Price to Free Cash Flow | 9.837 |
| Price | 1.76 |
| Earnings Yield | 1.48% |
| Normalized PE Ratio | 52.07 |